LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Foresight Enterprise VCT launches £30 million fundraise

Philip Roth by Philip Roth
October 16, 2023
in UK
Foresight Enterprise VCT launches £30 million fundraise
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


You might also like

Who will be on the touchline for Chelsea at Nottingham Forest after Maresca ban?

Premier Inn sales slip in UK despite boost from Oasis gigs

UK stuck in slow lane ahead of Budget with “meagre” 0.1% GDP growth in August

The Foresight Enterprise VCT has announced an offer for up to £30 million (£20 million + £10 million overallotment).

The VCT has net assets of £148.2 million and a portfolio of 44 companies, which targets established businesses with a low cash burn.

Over the five years to September 2023, the VCT generated a NAV total return of 32.3% and the VCT targets a dividend of 5% of NAV.

Nicholas Hyett, Investment Manager at Wealth Club said, “The Foresight Enterprise VCT targets more mature businesses, seeking investments that are either already breaking even or pretty close. That means it’s often the last external investor to provide funding to its investees.

The focus on later stage businesses, together with a large portfolio of older legacy assets, has helped the VCT develop an enviable track record of exits in recent times. A good chunk of the remaining portfolio is profitable, particularly in the top ten largest holdings, providing potential for further realisations in future.”



Source link

Share30Tweet19
Previous Post

BioNTech’s stock sinks after disclosing expected charge of up to nearly $1 billion resulting from Pfizer’s write offs of COVID products

Next Post

Novo Nordisk to buy hypertension treatment from for $1.3 billion from KBP Biosciences

Philip Roth

Philip Roth

Recommended For You

Who will be on the touchline for Chelsea at Nottingham Forest after Maresca ban?
UK

Who will be on the touchline for Chelsea at Nottingham Forest after Maresca ban?

October 16, 2025
Premier Inn sales slip in UK despite boost from Oasis gigs
UK

Premier Inn sales slip in UK despite boost from Oasis gigs

October 16, 2025
UK stuck in slow lane ahead of Budget with “meagre” 0.1% GDP growth in August
UK

UK stuck in slow lane ahead of Budget with “meagre” 0.1% GDP growth in August

October 16, 2025
Chelsea injury update: Palmer, Caicedo, James latest return dates
UK

Chelsea injury update: Palmer, Caicedo, James latest return dates

October 16, 2025
Next Post
Novo Nordisk to buy hypertension treatment from for .3 billion from KBP Biosciences

Novo Nordisk to buy hypertension treatment from for $1.3 billion from KBP Biosciences

Related News

Art Invest puts forward refurb plans for Sackville House in Mayfair

Art Invest puts forward refurb plans for Sackville House in Mayfair

October 17, 2023
UAE’s RAK Properties to accept Bitcoin, other cryptos for real estate deals

UAE’s RAK Properties to accept Bitcoin, other cryptos for real estate deals

September 1, 2025
Property with estate agents as tenants be sold at auction – London Wallet

Property with estate agents as tenants be sold at auction – London Wallet

April 26, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?